Daou BJ, Koduri S, Thompson BG, Chaudhary N, Pandey AS (2019) Clinical and experimental aspects of aneurysmal subarachnoid hemorrhage. CNS Neurosci Ther 25:1096–1112. https://doi.org/10.1111/cns.13222
Article PubMed PubMed Central Google Scholar
Fisher CM, Roberson GH, Ojemann RG (1977) Cerebral vasospasm with ruptured saccular aneurysm–the clinical manifestations. Neurosurgery 1:245–248. https://doi.org/10.1227/00006123-197711000-00004
Article CAS PubMed Google Scholar
Kosty T (2005) Cerebral vasospasm after subarachnoid hemorrhage: an update. Crit Care Nurs Q 28:122–134. https://doi.org/10.1097/00002727-200504000-00005
de Rooij NK, Greving JP, Rinkel GJ, Frijns CJ (2013) Early prediction of delayed cerebral ischemia after subarachnoid hemorrhage: development and validation of a practical risk chart. Stroke 44:1288–1294. https://doi.org/10.1161/strokeaha.113.001125
Dorhout Mees SM, Rinkel GJ, Feigin VL, Algra A, van den Bergh WM, Vermeulen M, van Gijn J (2007) Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 2007. https://doi.org/10.1002/14651858.CD000277.pub3
Liu J, Sun C, Wang Y, Nie G, Dong Q, You J, Li Q, Li M (2022) Efficacy of nimodipine in the treatment of subarachnoid hemorrhage: a meta-analysis. Arq Neuropsiquiatr 80:663–670. https://doi.org/10.1055/s-0042-1755301
Article PubMed PubMed Central Google Scholar
Petruk KC, West M, Mohr G, Weir BKA, Benoit BG, Gentili F, Disney LB, Khan MI, Grace M, Holness RO et al (1988) Nimodipine treatment in poor-grade aneurysm patients: results of a multicenter double-blind placebo-controlled trial. J Neurosurg 68:505–517. https://doi.org/10.3171/jns.1988.68.4.0505
Article CAS PubMed Google Scholar
Allen GS, Ahn HS, Preziosi TJ, Battye R, Boone SC, Boone SC, Chou SN, Kelly DL, Weir BK, Crabbe RA et al (1983) Cerebral arterial spasm–a controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med 308:619–624. https://doi.org/10.1056/nejm198303173081103
Article CAS PubMed Google Scholar
Philippon J, Grob R, Dagreou F, Guggiari M, Rivierez M, Viars P (1986) Prevention of vasospasm in subarachnoid haemorrhage. A controlled study with nimodipine. Acta Neurochir (Wien) 82:110–114. https://doi.org/10.1007/bf01456369
Article CAS PubMed Google Scholar
Pickard JD, Murray GD, Illingworth R, Shaw MD, Teasdale GM, Foy PM, Humphrey PR, Lang DA, Nelson R, Richards P et al (1989) Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ 298:636–642. https://doi.org/10.1136/bmj.298.6674.636
Article CAS PubMed PubMed Central Google Scholar
Petruk KC, West M, Mohr G, Weir BK, Benoit BG, Gentili F, Disney LB, Khan MI, Grace M, Holness RO et al (1988) Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial. J Neurosurg 68:505–517. https://doi.org/10.3171/jns.1988.68.4.0505
Article CAS PubMed Google Scholar
Hoh BL, Ko NU, Amin-Hanjani S, Chou S-Y, Cruz-Flores S, Dangayach NS, Derdeyn CP, Du R, Hänggi D, Hetts SW et al (2023) 2023 Guideline for the management of patients with Aneurysmal Subarachnoid Hemorrhage: a Guideline from the American Heart Association/American Stroke Association. Stroke 54:e314–e370. https://doi.org/10.1161/str.0000000000000436
Manning L, Hirakawa Y, Arima H, Wang X, Chalmers J, Wang J, Lindley R, Heeley E, Delcourt C, Neal B et al (2014) Blood pressure variability and outcome after acute intracerebral haemorrhage: a post-hoc analysis of INTERACT2, a randomised controlled trial. Lancet Neurol 13:364–373. https://doi.org/10.1016/s1474-4422(14)70018-3
Feigin VL, Rinkel GJ, Algra A, Vermeulen M, van Gijn J (1998) Calcium antagonists in patients with aneurysmal subarachnoid hemorrhage: a systematic review. Neurology 50:876–883. https://doi.org/10.1212/wnl.50.4.876
Article CAS PubMed Google Scholar
Al-Mufti F, Amuluru K, Damodara N, El-Ghanem M, Nuoman R, Kamal N, Al-Marsoummi S, Morris NA, Dangayach NS, Mayer SA (2018) Novel management strategies for medically-refractory vasospasm following aneurysmal subarachnoid hemorrhage. J Neurol Sci 390:44–51. https://doi.org/10.1016/j.jns.2018.02.039
Article CAS PubMed Google Scholar
Clifford KM, Madhok J, Murray NM, Mohindra V (2020) Rescue of Nimodipine-Induced Refractory Vasoplegia with Hydroxocobalamin in Subarachnoid Hemorrhage: a Case Report. Crit Care Explor 2:e0205. https://doi.org/10.1097/cce.0000000000000205
Article PubMed PubMed Central Google Scholar
Levy B, Fritz C, Tahon E, Jacquot A, Auchet T, Kimmoun A (2018) Vasoplegia treatments: the past, the present, and the future. Crit Care 22:52. https://doi.org/10.1186/s13054-018-1967-3
Article PubMed PubMed Central Google Scholar
Bele S, Scheitzach J, Kieninger M, Hochreiter A, Schödel P, Bründl E, Schebesch K-M, Brawanski A (2014) Vasoplegic syndrome after oral nimodipine application in patients with subarachnoid hemorrhage. Journal of Anesthesia & Critical Care: Open Access 1
Huang RQ, Jiang FG, Feng ZM, Wang TY (2013) Nicardipine in the treatment of aneurysmal subarachnoid haemorrhage: a meta-analysis of published data. Acta Neurol Belg 113:3–6. https://doi.org/10.1007/s13760-012-0142-x
Sadan O, Waddel H, Moore R, Feng C, Mei Y, Pearce D, Kraft J, Pimentel C, Mathew S, Akbik F et al (2022) Does intrathecal nicardipine for cerebral vasospasm following subarachnoid hemorrhage correlate with reduced delayed cerebral ischemia? A retrospective propensity score–based analysis. J Neurosurg 136:115–124. https://doi.org/10.3171/2020.12.JNS203673
Article CAS PubMed Google Scholar
Barth M, Capelle HH, Weidauer S, Weiss C, Münch E, Thomé C, Luecke T, Schmiedek P, Kasuya H, Vajkoczy P (2007) Effect of nicardipine prolonged-release implants on cerebral vasospasm and clinical outcome after severe aneurysmal subarachnoid hemorrhage: a prospective, randomized, double-blind phase IIa study. Stroke 38:330–336. https://doi.org/10.1161/01.STR.0000254601.74596.0f
Article CAS PubMed Google Scholar
Collins L, Lam L, Kleinig O, Proudman W, Zhang R, Bagster M, Kovoor J, Gupta A, Goh R, Bacchi S et al (2023) Verapamil in the treatment of reversible cerebral vasoconstriction syndrome: a systematic review. J Clin Neurosci 113:130–141. https://doi.org/10.1016/j.jocn.2023.05.013
Article CAS PubMed Google Scholar
Mikeladze KG, Okishev DN, Belousova OB, Konovalov AN, Pilipenko YV, Ageev IS, Kaftanov AN, Shekhtman OD, Kurdyumova NV, Tabasaransky TF et al (2020) Intra-arterial administration of Verapamil for the Prevention and Treatment of Cerebral Angiospasm. Acta Neurochir Suppl 127:179–183. https://doi.org/10.1007/978-3-030-04615-6_28
Article CAS PubMed Google Scholar
Mao G, Gigliotti MJ, Esplin N, Sexton K (2021) The clinical impact and safety profile of high-dose intra-arterial verapamil treatment for cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Clin Neurol Neurosurg 202:106546. https://doi.org/10.1016/j.clineuro.2021.106546
Hollingworth M, Chen PR, Goddard AJ, Coulthard A, Söderman M, Bulsara KR (2015) Results of an International Survey on the investigation and Endovascular Management of Cerebral Vasospasm and delayed cerebral ischemia. World Neurosurg 83:1120–1126e1121. https://doi.org/10.1016/j.wneu.2015.01.036
Keuskamp J, Murali R, Chao KH (2008) High-dose intraarterial verapamil in the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. J Neurosurg 108:458–463. https://doi.org/10.3171/jns/2008/108/3/0458
Article CAS PubMed Google Scholar
Sehy JV, Holloway WE, Lin S-P III, Derdeyn DTC, Moran CP (2010) Improvement in Angiographic Cerebral Vasospasm after Intra-arterial Verapamil Administration. Am J Neuroradiol 31:1923–1928. https://doi.org/10.3174/ajnr.A2215
Article CAS PubMed PubMed Central Google Scholar
Stuart RM, Helbok R, Kurtz P, Schmidt M, Fernandez L, Lee K, Badjatia N, Mayer SA, Lavine S, Meyers P et al (2011) High-dose intra-arterial verapamil for the treatment of cerebral vasospasm after subarachnoid hemorrhage: prolonged effects on hemodynamic parameters and brain metabolism. Neurosurgery 68:337–345. https://doi.org/10.1227/NEU.0b013e318201be47
Comments (0)